One of the biggest stories in obesity medicine over the past year has been the decision by tennis legend Serena Williams to speak publicly about her use of GLP-1 weight-loss medication.
As one of the most successful athletes in history, Serena Williams has become one of the highest-profile advocates for medically supervised weight management. Her decision to discuss her own experience has generated significant media attention and sparked debate about obesity treatment, weight stigma and the role of medications such as Wegovy and Mounjaro.
At Harley Street Obesity Clinic, we believe Serena Williams' story highlights an important message: obesity and weight management are complex medical issues that can affect anyone, regardless of fitness level, success or lifestyle.
Why Serena Williams Chose GLP-1 Treatment
Serena Williams revealed that she struggled to return to a healthy weight after the birth of her second child in 2023. Despite being one of the most accomplished athletes in the world, she explained that exercise and healthy eating alone were not producing the results she hoped for.
In 2025, she became a patient ambassador for the telehealth company Ro and publicly disclosed her use of GLP-1 medication as part of her weight-management journey. Williams stated that the treatment helped her lose more than 30 pounds while improving her overall health and wellbeing.
More recently, she has appeared in a national campaign discussing how weight loss improved her mobility, reduced stress on her joints and helped her feel healthier overall.
Challenging the Stigma Around Weight-Loss Medication
One of the reasons Serena Williams' story has attracted so much attention is that it challenges a common misconception about weight-loss medication.
Many people assume that only those who do not exercise or who have poor dietary habits struggle with their weight. Serena's experience demonstrates that weight management is influenced by many factors, including:
- Hormonal changes
- Pregnancy and childbirth
- Genetics
- Metabolism
- Medical conditions
- Age-related changes
Williams has spoken openly about initially worrying that medication might be viewed as a "shortcut" before concluding that obesity treatment should be viewed as healthcare rather than a personal failing.
Not Everyone Agrees
As with many high-profile health stories, Serena Williams' decision to become a public advocate for GLP-1 treatment has generated debate.
Some commentators have praised her openness and believe celebrity voices can help reduce stigma around obesity treatment and encourage people to seek medical support. Others have questioned whether celebrity endorsements risk oversimplifying complex medical treatments.
Regardless of where people stand on the debate, one thing is clear: conversations about obesity treatment are becoming more open than ever before.
What Patients Should Take Away
The most important lesson from Serena Williams' experience is not that everyone should take weight-loss medication.
Instead, it highlights that:
- Obesity is a chronic medical condition
- Weight struggles can affect people from all backgrounds
- Effective treatment often requires medical support
- There is no single solution that works for everyone
- Treatment should always be personalised
For some patients, lifestyle changes alone may be sufficient. Others may benefit from medications such as Mounjaro or Wegovy. Some patients may ultimately consider bariatric procedures such as gastric sleeve surgery.
The right approach depends on the individual.
The Importance of Medical Supervision
GLP-1 medications can be highly effective when prescribed appropriately, but they are not suitable for everyone.
Patients considering treatment should undergo a full medical assessment to determine:
- Whether medication is appropriate
- Which treatment option is most suitable
- How progress should be monitored
- What long-term maintenance strategy should be used
Successful weight management is about more than simply losing weight. It is about improving health and maintaining results safely over the long term.
How Harley Street Obesity Clinic Can Help
At Harley Street Obesity Clinic, we provide medically led weight-management programmes tailored to each patient.
Our multidisciplinary team includes specialist doctors, bariatric nurses and dietitians who work together to provide:
- Comprehensive medical assessments
- Access to evidence-based weight-loss treatments
- Nutritional and behavioural support
- Long-term weight-maintenance planning
- Advice on both medication and surgical options
We understand that every patient's journey is different and our goal is to help you find the treatment pathway that is right for you.
Take the Next Step
If you are considering weight-loss injections such as Mounjaro or Wegovy and would like expert advice on whether they may be appropriate for you, our team is here to help.